Iris reconstruction combined with iris-claw intraocular lens implantation for the management of iris-lens injured patients.

ABSTRACT

Aim: To study the efficiency and safety of iris reconstruction combined with iris‑claw intraocular lens (IOL) implantation in the patients with iris‑lens injuries. Settings and Design: Retrospective, noncomparable consecutive case series study. Materials and Methods: Eleven patients (11 eyes) following iris‑lens injuries underwent iris reconstructions combined with iris‑claw IOL implantations. Clinical data, such as cause and time of injury, visual acuity (VA), iris and lens injuries, surgical intervention, follow‑up period, corneal endothelial cell count, and optical coherence tomography, were collected. Results: Uncorrected VA (UCVA) in all injured eyes before combined surgery was equal to or <20/1000. Within a 1.1–4.2‑year follow‑up period, a significant increase, equal to or better than 20/66, in UCVA was observed in six (55%) cases, and in best‑corrected VA (BCVA) was observed in nine (82%) cases. Postoperative BCVA was 20/40 or better in seven cases (64%). After combined surgery, the iris returned to its natural round shape or smaller pupil, and the iris‑claw IOLs in the 11 eyes were well‑positioned on the anterior surface of reconstructed iris. No complications occurred in those patients. Conclusions: Iris reconstruction combined with iris‑claw IOL implantation is a safe and efficient procedure for an eye with iris‑lens injury in the absence of capsular support.